ELi rahvatervise juhtimine

Improving health systems

Hea tervise edendamine

Medical devices

Substances of human origin

Veri, koed ja elundid

Farmaatsiatooted

Haigustevastased meetmed

Riskihindamine

Teaduskomiteed

Endocrine disruptors

Endocrine disruptors

Biocides

Biocides

Konsultatsioonid

Closed consultations

22 Juuni - 22 Juuli 2020

Targeted stakeholder consultation on the pilot project ‘Market Launch Intentions of Centrally Authorised Products’
16 Juuni - 15 September 2020

Pharmaceuticals – safe and affordable medicines (new EU strategy)
02 Juuni - 07 Juuli 2020

Pharmaceutical Strategy Roadmap
20 Märts - 20 Juuni 2020

Targeted stakeholders' consultation on Annex 21: Importation of medicinal products, of the Eudralex volume 4
20 Veebruar - 20 Mai 2020

Second targeted stakeholders' consultation on the revision of Annex 1, on manufacturing of sterile medicinal products, of Eudralex volume 4
29 Jaanuar - 28 Aprill 2019

Targeted consultation on the guideline on the format and content of applications for designation as orphan medicinal products and on the transfer of designations from one sponsor to another
18 Oktoober 2018 - 04 Jaanuar 2019

Public consultation on legislation on medicines for children and rare diseases
01 August - 31 Oktoober 2018

Targeted stakeholder consultation on the draft Guidelines on Good Clinical Practice for Advanced Therapy Medicinal Products
18 Mai - 10 September 2018

Targeted stakeholder consultation on duplicate marketing authorisations for biological medicinal products
02 Mai - 02 August 2018

Study supporting the Evaluation of the European Medicines Agency Fee System

Pages